Avid Bioservices — Company Overview, News & Financial Data

Avid Bioservices (NASDAQ:CDMO) specializes in biologics contract development and manufacturing organization (CDMO) services, focusing on biopharmaceutical drug development and commercialization. This entails a range of activities from process development to clinical and commercial drug substance manufacturing, packaging, and labeling. Avid's principal objective is to support biotech and pharmaceutical companies in bringing their innovative treatments to market efficiently and cost-effectively, leveraging its state-of-the-art facilities and deep expertise in the field. With a commitment to quality, compliance, and customer satisfaction, Avid plays a crucial role in the rapidly evolving biopharma industry, adapting to meet the ever-changing needs of its global client base.